交易 TFF Pharmaceuticals, Inc. - TFFP CFD
新增到我的最愛- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
- 所有權
交易條件
價差 | 0.05 | ||||||||
多頭倉位隔夜費用
多頭倉位隔夜費用
前往平台 | -0.026151% | ||||||||
空頭倉位隔夜費用
空頭倉位隔夜費用
前往平台 | 0.003929% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|---|---|---|---|---|---|
Sep 15, 2023 | 0.38 | 0.00 | 0.00% | 0.38 | 0.38 | 0.37 |
Aug 24, 2023 | 0.38 | 0.01 | 2.70% | 0.37 | 0.38 | 0.37 |
Aug 23, 2023 | 0.38 | 0.00 | 0.00% | 0.38 | 0.38 | 0.38 |
Aug 22, 2023 | 0.39 | 0.01 | 2.63% | 0.38 | 0.39 | 0.38 |
Aug 21, 2023 | 0.38 | 0.00 | 0.00% | 0.38 | 0.38 | 0.38 |
Aug 16, 2023 | 0.37 | -0.03 | -7.50% | 0.40 | 0.40 | 0.37 |
Aug 15, 2023 | 0.39 | -0.02 | -4.88% | 0.41 | 0.50 | 0.39 |
Aug 14, 2023 | 0.40 | -0.01 | -2.44% | 0.41 | 0.42 | 0.40 |
Aug 11, 2023 | 0.39 | 0.00 | 0.00% | 0.39 | 0.39 | 0.39 |
Aug 8, 2023 | 0.38 | 0.00 | 0.00% | 0.38 | 0.38 | 0.38 |
Aug 7, 2023 | 0.38 | -0.02 | -5.00% | 0.40 | 0.45 | 0.38 |
Aug 4, 2023 | 0.41 | 0.02 | 5.13% | 0.39 | 0.42 | 0.39 |
Aug 3, 2023 | 0.39 | -0.02 | -4.88% | 0.41 | 0.41 | 0.39 |
Aug 2, 2023 | 0.39 | -0.03 | -7.14% | 0.42 | 0.43 | 0.39 |
Aug 1, 2023 | 0.40 | 0.00 | 0.00% | 0.40 | 0.41 | 0.40 |
Jul 31, 2023 | 0.41 | 0.01 | 2.50% | 0.40 | 0.41 | 0.39 |
Jul 6, 2023 | 0.39 | 0.00 | 0.00% | 0.39 | 0.39 | 0.39 |
Jul 5, 2023 | 0.41 | -0.06 | -12.77% | 0.47 | 0.47 | 0.39 |
Jul 3, 2023 | 0.46 | 0.02 | 4.55% | 0.44 | 0.47 | 0.44 |
Jun 30, 2023 | 0.44 | 0.03 | 7.32% | 0.41 | 0.44 | 0.41 |
TFF Pharmaceuticals, Inc. Events
时间(协调世界时) (UTC) | 國家 | 事件 |
---|---|---|
Monday, November 13, 2023 | ||
时间(协调世界时) (UTC) 10:59 | 國家 US
| 事件 Q3 2023 TFF Pharmaceuticals Inc Earnings Release Q3 2023 TFF Pharmaceuticals Inc Earnings ReleaseForecast(預報) -上一頁 - |
Tuesday, March 5, 2024 | ||
时间(协调世界时) (UTC) 10:59 | 國家 US
| 事件 Q4 2023 TFF Pharmaceuticals Inc Earnings Release Q4 2023 TFF Pharmaceuticals Inc Earnings ReleaseForecast(預報) -上一頁 - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 0.49581 | 0.08816 | 0 | 0 | 0 |
總營業費用 | 32.2926 | 31.8748 | 18.6936 | 11.9876 | 3.89815 |
銷售/一般/行政費用,總計 | 13.7963 | 10.5739 | 8.01209 | 3.16533 | 3.04934 |
研究與開發 | 18.4963 | 21.3009 | 10.6816 | 8.82223 | 0.84881 |
營業收入 | -31.7968 | -31.7867 | -18.6936 | -11.9876 | -3.89815 |
稅前淨收入 | -31.7701 | -31.0387 | -18.5672 | -11.8702 | -3.84219 |
稅後淨收入 | -31.7701 | -31.0387 | -18.5672 | -11.8702 | -3.84219 |
未計算非常項目前的淨收益 | -31.7701 | -31.0387 | -18.5672 | -11.8702 | -3.84219 |
淨收入 | -31.7701 | -31.0387 | -18.5672 | -11.8702 | -3.84219 |
普通股股東可獲收益 (不含非經常性項目) | -31.7701 | -31.0387 | -18.5672 | -36.6753 | -4.57054 |
普通股股東可獲收益 (含非經常性項目) | -31.7701 | -31.0387 | -18.5672 | -36.6753 | -4.57054 |
攤薄淨收入 | -31.7701 | -31.0387 | -18.5672 | -36.6753 | -4.57054 |
攤薄後加權平均股 | 29.9798 | 24.821 | 20.4252 | 18.451 | 17.8254 |
扣除特別項目的每股攤薄盈利 | -1.05972 | -1.2505 | -0.90904 | -1.98772 | -0.25641 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
每股正常攤薄盈利 | -1.05972 | -1.2505 | -0.90904 | -1.98772 | -0.25641 |
利息收入(費用),非經營淨值 | 0.02673 | 0.05123 | 0.12642 | 0.11733 | 0.05596 |
Total Adjustments to Net Income | 0 | -24.8051 | -0.72835 | ||
收入 | 0.49581 | 0.08816 | |||
其他,淨值 | 0 | 0.69671 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0.33335 | 0.05143 | 0.31278 | 0.08759 | 0.028 |
收入 | 0.33335 | 0.05143 | 0.31278 | 0.08759 | 0.028 |
總營業費用 | 5.35226 | 7.13788 | 7.69356 | 7.36821 | 8.80082 |
銷售/一般/行政費用,總計 | 2.67036 | 3.11922 | 3.55751 | 3.34227 | 3.69001 |
研究與開發 | 2.6819 | 4.01866 | 4.13605 | 4.02594 | 5.11081 |
營業收入 | -5.01891 | -7.08645 | -7.38078 | -7.28062 | -8.77282 |
利息收入(費用),非經營淨值 | -0.0013 | 0.03508 | 0.00754 | 0.00612 | 0.00588 |
其他,淨值 | 0 | 0 | 0.02061 | ||
稅前淨收入 | -5.02021 | -7.05137 | -7.37323 | -7.2745 | -8.74633 |
稅後淨收入 | -5.02021 | -7.05137 | -7.37323 | -7.2745 | -8.74633 |
未計算非常項目前的淨收益 | -5.02021 | -7.05137 | -7.37323 | -7.2745 | -8.74633 |
淨收入 | -5.02021 | -7.05137 | -7.37323 | -7.2745 | -8.74633 |
普通股股東可獲收益 (不含非經常性項目) | -5.02021 | -7.05137 | -7.37323 | -7.2745 | -8.74633 |
普通股股東可獲收益 (含非經常性項目) | -5.02021 | -7.05137 | -7.37323 | -7.2745 | -8.74633 |
攤薄淨收入 | -5.02021 | -7.05137 | -7.37323 | -7.2745 | -8.74633 |
攤薄後加權平均股 | 36.1931 | 36.1931 | 29.9798 | 25.4517 | 25.3737 |
扣除特別項目的每股攤薄盈利 | -0.13871 | -0.19483 | -0.24594 | -0.28582 | -0.3447 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.13871 | -0.19483 | -0.24594 | -0.28582 | -0.3447 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動負債總額 | 1.13066 | 1.96075 | 1.32204 | 0.41064 | 1.157 |
應付賬款 | 0.91961 | 1.49384 | 1.29773 | 0.41064 | 0.42865 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
負債總額 | 1.24076 | 1.96075 | 1.32204 | 1.54265 | 1.157 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
總權益 | 22.8795 | 38.7371 | 37.3398 | 27.6448 | 9.24451 |
留存收益(累計赤字) | -97.0884 | -65.3184 | -34.2797 | -15.7124 | -3.84219 |
總負債和股東權益 | 24.1202 | 40.6978 | 38.6618 | 29.1874 | 10.4015 |
已發行普通股總數 | 36.1931 | 25.3718 | 22.5349 | 18.451 | 17.8254 |
流動資産總額 | 19.0252 | 38.838 | 37.559 | 29.1874 | 10.2737 |
現金和短期投資 | 16.6123 | 33.7947 | 35.3008 | 28.0949 | 10.2617 |
現金等價物 | 16.6123 | 33.7947 | 35.3008 | 28.0949 | 10.2617 |
預付的費用 | 2.22634 | 2.44793 | 2.25823 | 1.09246 | 0.01207 |
總資産 | 24.1202 | 40.6978 | 38.6618 | 29.1874 | 10.4015 |
其他長期資産,總計 | 0.00769 | 0 | 0.12777 | ||
預提費用 | 0.08506 | 0.41691 | 0 | 0.72835 | |
Preferred Stock - Non Redeemable, Net | 12.486 | ||||
普通股 | 0.03619 | 0.02537 | 0.02254 | 0.01845 | 0.004 |
額外實收資本 | 120.071 | 104.079 | 71.6485 | 43.3387 | 0.59672 |
其他負債,總計 | 0.11009 | 0 | 1.13201 | ||
Redeemable Preferred Stock | 0 | ||||
物業/廠房/設備,總計 - 淨額 | 3.27439 | 1.85986 | 1.10281 | ||
其他流動負債,總計 | 0.126 | 0.05 | 0.02432 | ||
其他權益,總計 | -0.1393 | -0.04892 | -0.05154 | ||
應收賬款總額,淨額 | 0.18651 | 2.59535 | |||
應收票據 - 長期 | 1.81298 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
流動資産總額 | 13.9604 | 19.0252 | 16.979 | 25.1817 | 31.524 |
現金和短期投資 | 12.2164 | 16.6123 | 13.1471 | 20.8902 | 26.4142 |
現金等價物 | 12.2164 | 16.6123 | 13.1471 | 20.8902 | 26.4142 |
預付的費用 | 1.55531 | 2.22634 | 1.06976 | 1.48395 | 2.16445 |
總資産 | 18.2117 | 24.1202 | 20.2274 | 27.9132 | 33.7828 |
物業/廠房/設備,總計 - 淨額 | 2.40387 | 3.27439 | 3.24073 | 2.56439 | 2.25874 |
流動負債總額 | 1.57684 | 1.13066 | 2.07657 | 3.82751 | 2.19678 |
應付賬款 | 1.34443 | 0.91961 | 1.63402 | 3.48046 | 2.02878 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 0.151 | 0.126 | 0.36271 | 0.268 | 0.168 |
負債總額 | 1.66837 | 1.24076 | 2.20489 | 3.9737 | 2.19678 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
總權益 | 16.5433 | 22.8795 | 18.0225 | 23.9395 | 31.586 |
普通股 | 0.03619 | 0.03619 | 0.02552 | 0.02537 | 0.02537 |
額外實收資本 | 120.805 | 120.071 | 107.923 | 106.462 | 105.257 |
留存收益(累計赤字) | -104.14 | -97.0884 | -89.7152 | -82.4407 | -73.6944 |
其他權益,總計 | -0.15796 | -0.1393 | -0.21035 | -0.10712 | -0.00169 |
總負債和股東權益 | 18.2117 | 24.1202 | 20.2274 | 27.9132 | 33.7828 |
已發行普通股總數 | 36.1931 | 36.1931 | 25.5181 | 25.3738 | 25.3718 |
應收賬款總額,淨額 | 0.18877 | 0.18651 | 2.76214 | 2.80752 | 2.94541 |
預提費用 | 0.08141 | 0.08506 | 0.07984 | 0.07905 | 0 |
其他長期資産,總計 | 0.00769 | 0.00769 | 0.00769 | 0.16708 | |
其他負債,總計 | 0.09152 | 0.11009 | 0.12831 | 0.14619 | |
應收票據 - 長期 | 1.83969 | 1.81298 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -31.7701 | -31.0387 | -18.5672 | -11.8702 | -3.84219 |
經營活動産生的現金 | -27.3422 | -29.557 | -16.6156 | -11.2161 | -2.12699 |
營運資金的變化 | -0.55108 | -1.59719 | -0.25982 | 0.06407 | 0.38612 |
投資活動産生的現金 | -1.55133 | -0.86851 | -1.10281 | 0 | 0 |
其他投資現金流量項目,總計 | 0 | 0 | |||
融資活動産生的現金 | 11.751 | 28.885 | 24.9947 | 29.0494 | 12.3887 |
融資現金流項目 | 0 | -0.09731 | |||
現金淨變化 | -17.1824 | -1.50613 | 7.20587 | 17.8333 | 10.2617 |
非現金物品 | 4.59076 | 2.96748 | 2.21146 | 0.59004 | 1.32907 |
股票的發行(報廢),淨額 | 11.751 | 28.885 | 24.9947 | 29.0494 | 12.486 |
經營活動産生的現金 | 0.38822 | 0.11145 | 0 | ||
資本支出 | -1.55133 | -0.86851 | -1.10281 | ||
外彙效應 | -0.03987 | 0.03436 | -0.0704 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -7.05137 | -31.7701 | -24.3968 | -17.1223 | -8.376 |
Cash From Operating Activities | -4.36578 | -27.3422 | -19.6402 | -12.2607 | -7.2463 |
Cash From Operating Activities | 0.12317 | 0.38822 | 0.26731 | 0.16617 | 0.07703 |
Non-Cash Items | 1.44312 | 4.59076 | 2.80813 | 1.87762 | 0.6527 |
Changes in Working Capital | 1.1193 | -0.55108 | 1.68119 | 2.81779 | 0.39998 |
Cash From Investing Activities | 0 | -1.55133 | -1.41016 | -0.63268 | -0.13723 |
Capital Expenditures | 0 | -1.55133 | -1.41016 | -0.63268 | -0.13723 |
Cash From Financing Activities | -0.01792 | 11.751 | 0.41474 | -0.016 | 0 |
Issuance (Retirement) of Stock, Net | 11.751 | 0.41474 | 0.01019 | 0 | |
Foreign Exchange Effects | -0.01225 | -0.03987 | -0.01197 | 0.00501 | 0.00303 |
Net Change in Cash | -4.39596 | -17.1824 | -20.6476 | -12.9044 | -7.3805 |
Financing Cash Flow Items | -0.01792 | -0.02618 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
Industry: | Biotechnology & Medical Research (NEC) |
2600 Via Fortuna Ste 360
AUSTIN
TEXAS 78746-7983
US
收入報表
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 555.000 多名交易者,選擇與 Capital.com 交易